Cell wall synthesis enzymes and beta-lactam resistance in Enterococcus faecium

屎肠球菌细胞壁合成酶和β-内酰胺耐药性

基本信息

  • 批准号:
    8264326
  • 负责人:
  • 金额:
    $ 37.61万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2001
  • 资助国家:
    美国
  • 起止时间:
    2001-03-01 至 2015-05-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): More than any other human pathogen, Enterococcus. faecium has grown in importance as a result of its resistance to commonly used antimicrobial agents, in particular to the ?-lactams. High-level ? lactam resistance expressed by E. faecium not only compromises therapy of bacterial infections, it promotes gastrointestinal colonization and further dissemination of resistant strains. The hallmark of high-level ?-lactam resistance in E. faecium is the expression of low affinity class B penicillin-binding protein Pbp5. As a class B Pbp with only transpeptidase activity, Pbp5 must coordinate its activities with that of glycosyltransferases to synthesize mature peptidoglycan. Class B Pbps most commonly coordinate with bifunctional (possessing both glycosyltransferase and transpeptidase activities) class A Pbps, which in E. faecium are PbpF, PbpZ and PonA. In work performed during the previous period of this grant, we described auxiliary and parallel mechanisms by which E. faecium expresses resistance to ?-lactam antibiotics. We have deleted the E. faecium class A pbps in every combination and have discovered that deletion of PbpF and PonA results in a heterogeneous susceptibility to ceftriaxone (suggesting that Pbp5 coordinated with either of these class A Pbps to confer resistance to ceftriaxone), from which homogeneous resistance can be selected by growth on ceftriaxone (selection of spontaneous mutants) or induced by exposure to penicillin. Loss of PbpF is also associated with the autolytic phenotype of E. faecium. We have also identified and characterized an L,D-transpeptidase (Ldtfm) that is able to confer ?-lactam and vancomycin resistance in the absence of Pbp5, in concert with the activity of a D,D-carboxypeptidase. The present proposal will continue with this important work in the following manner: 1) We will investigate the mechanisms underlying the class A Pbp deletion phenotypes by characterizing the E. faecium peptidoglycan synthesis complex, targeting a likely alternative glycosyltransferases identified through a genome search and using microarray analysis to analyze the regulatory framework of penicillin-inducible ceftriaxone resistance in the ponApbpF double mutant 2) We will investigate the mechanisms underlying PbpF ceftriaxone-moenomycin synergism vs. E. faecium D344R and the impact of PbpF on the autolytic phenotype through site-directed mutagenesis of PbpF and functional studies of E. faecium autolysins 3) We will explore the molecular basis for the substrate specificity of Ldtfm to understand the surprising pattern of inhibition of the enzyme by ?-lactams 4) We will characterize the physiological aspects of the L,D-transpeptidation pathway using a proteomic approach to identifying partners of Ldtfm in the peptidoglycan polymerization complexes. We will also use transcriptome analysis to identify differentially expressed genes and perform whole genome sequencing to identify all of the mutations leading to expression of high levels of ampicillin and vancomycin resistance through the Ldtfm pathway. These investigations will identify and characterize critical and redundant ?-lactam resistance mechanisms in a bacterial species in which ?-lactam resistance is absolutely essential to its propagation in the hospital setting. They will also enhance our understanding of cell wall synthesis mechanisms in Gram-positive cocci and reveal promising new targets for antibacterial therapy. PUBLIC HEALTH RELEVANCE: Enterococcus faecium is a common and increasingly important cause of nosocomial infections. Its characteristic high level of resistance to ?-lactam antibiotics limits treatment and promotes dissemination. This project aims to identify and characterize the complex and redundant mechanisms of ?-lactam resistance in an effort to better understand enterococcal physiology and promote identification of novel therapeutic targets.
描述(由申请人提供):肠球菌比任何其他人类病原体都多。由于其对常用抗菌剂的耐药性,特别是对?内酰胺。高级?内酰胺类耐药表现为E.屎肠菌不仅损害细菌感染的治疗,而且促进胃肠道定植和耐药菌株的进一步传播。高水平的标志?内酰胺类耐药大肠杆菌。屎肠是低亲和力B类青霉素结合蛋白Pbp 5的表达。Pbp 5是一种仅具有转肽酶活性的B类Pbp,必须与糖基转移酶协调其活性以合成成熟肽聚糖。B类Pbp最常与双功能(具有糖基转移酶和转肽酶活性)的A类Pbp配位,其在E. pbpF、pbpZ和PonA。在本基金前期的工作中,我们描述了辅助和平行机制,通过这些机制E。屎肠对?内酰胺类抗生素我们删除了E。已经发现PbpF和PonA的缺失导致对头孢曲松的异质性易感性(表明Pbp 5与这些A类Pbp中的任一个协调以赋予对头孢曲松的抗性),由此可以通过在头孢曲松上生长(自发突变体的选择)或通过暴露于青霉素诱导来选择同质抗性。PbpF的缺失也与E.屎室我们还确定了L,D-转肽酶(Ldtfm),能够赋予?内酰胺和万古霉素耐药性,与D,D-羧肽酶的活性一致。本研究将以如下方式继续这一重要工作:1)我们将通过鉴定E.屎肠肽聚糖合成复合物,靶向通过基因组搜索鉴定的可能的替代糖基转移酶,并使用微阵列分析来分析ponApbpF双突变体中青霉素诱导的头孢曲松耐药性的调控框架。faecium D344 R的研究以及PbpF对自溶表型的影响。3)我们将探索Ldtfm底物特异性的分子基础,以了解?4)我们将使用蛋白质组学方法表征L,D-转肽途径的生理学方面,以鉴定肽聚糖聚合复合物中Ldtfm的配偶体。我们还将使用转录组分析来鉴定差异表达的基因,并进行全基因组测序,以鉴定通过Ldtfm途径导致高水平氨苄青霉素和万古霉素耐药表达的所有突变。这些调查将确定和描述关键和冗余的?内酰胺耐药机制的细菌物种,其中?内酰胺抗性对其在医院环境中的传播是绝对必要的。它们还将增强我们对革兰氏阳性球菌细胞壁合成机制的理解,并揭示有希望的抗菌治疗新靶点。 公共卫生相关性:屎肠球菌是医院感染的常见且日益重要的原因。它的特点是对?-内酰胺类抗生素限制了治疗并促进了传播。该项目旨在识别和表征?-内酰胺耐药性,以更好地了解肠球菌生理学和促进新的治疗靶点的鉴定。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Louis B. Rice其他文献

Inhibitor resistant class A beta-lactamases.
抑制剂抗性 A 类 β-内酰胺酶。
  • DOI:
  • 发表时间:
    1999
  • 期刊:
  • 影响因子:
    0
  • 作者:
    R. A. Bonomo;Louis B. Rice
  • 通讯作者:
    Louis B. Rice
Efficacy of oxacillin and ampicillin-sulbactam combination in experimental endocarditis caused by beta-lactamase-hyperproducing Staphylococcus aureus
苯唑西林联合氨苄西林舒巴坦治疗高产β-内酰胺酶金黄色葡萄球菌引起的实验性心内膜炎的疗效
Efficacy of different beta-lactams against an extended-spectrum beta-lactamase-producing Klebsiella pneumoniae strain in the rat intra-abdominal abscess model.
不同β-内酰胺对大鼠腹内脓肿模型中产生广谱β-内酰胺酶的肺炎克雷伯菌菌株的功效。
  • DOI:
  • 发表时间:
    1991
  • 期刊:
  • 影响因子:
    4.9
  • 作者:
    Louis B. Rice;Joseph D. C. Yao;K. Klimm;G. M. Eliopoulos;R. Moellering
  • 通讯作者:
    R. Moellering
The prevalence of sequences homologous to IS256 in clinical enterococcal isolates.
临床肠球菌分离株中与 IS256 同源的序列的普遍性。
  • DOI:
  • 发表时间:
    1994
  • 期刊:
  • 影响因子:
    2.6
  • 作者:
    Louis B. Rice;Anna S. Thorisdottir
  • 通讯作者:
    Anna S. Thorisdottir
Enterococcal endocarditis: a comparison of prosthetic and native valve disease.
肠球菌性心内膜炎:人工瓣膜疾病和自体瓣膜疾病的比较。
  • DOI:
    10.1093/clinids/13.1.1
  • 发表时间:
    1991
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Louis B. Rice;Stephen B. Calderwood;G. M. Eliopoulos;Bruce F. Farber;A. Karchmer
  • 通讯作者:
    A. Karchmer

Louis B. Rice的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Louis B. Rice', 18)}}的其他基金

Ampicillin resistance mechanisms in E. faecium
屎肠球菌的氨苄西林耐药机制
  • 批准号:
    7371920
  • 财政年份:
    2001
  • 资助金额:
    $ 37.61万
  • 项目类别:
REGULATION OF AMPICILLIN RESISTANCE IN E FACEIUM
E FACEIUM 中氨苄青霉素耐药性的调节
  • 批准号:
    6632105
  • 财政年份:
    2001
  • 资助金额:
    $ 37.61万
  • 项目类别:
Ampicillin resistance mechanisms in E. faecium
屎肠球菌的氨苄西林耐药机制
  • 批准号:
    6869221
  • 财政年份:
    2001
  • 资助金额:
    $ 37.61万
  • 项目类别:
REGULATION OF AMPICILLIN RESISTANCE IN E FACEIUM
E FACEIUM 中氨苄青霉素耐药性的调节
  • 批准号:
    6261158
  • 财政年份:
    2001
  • 资助金额:
    $ 37.61万
  • 项目类别:
Ampicillin resistance mechanisms in E. faecium
屎肠球菌的氨苄西林耐药机制
  • 批准号:
    7193457
  • 财政年份:
    2001
  • 资助金额:
    $ 37.61万
  • 项目类别:
Cell wall synthesis enzymes and beta-lactam resistance in Enterococcus faecium
屎肠球菌细胞壁合成酶和β-内酰胺耐药性
  • 批准号:
    8659332
  • 财政年份:
    2001
  • 资助金额:
    $ 37.61万
  • 项目类别:
REGULATION OF AMPICILLIN RESISTANCE IN E FACEIUM
E FACEIUM 中氨苄青霉素耐药性的调节
  • 批准号:
    6701296
  • 财政年份:
    2001
  • 资助金额:
    $ 37.61万
  • 项目类别:
Cell wall synthesis enzymes and beta-lactam resistance in Enterococcus faecium
屎肠球菌细胞壁合成酶和β-内酰胺耐药性
  • 批准号:
    8080880
  • 财政年份:
    2001
  • 资助金额:
    $ 37.61万
  • 项目类别:
Cell wall synthesis enzymes and beta-lactam resistance in Enterococcus faecium
屎肠球菌细胞壁合成酶和β-内酰胺耐药性
  • 批准号:
    8469377
  • 财政年份:
    2001
  • 资助金额:
    $ 37.61万
  • 项目类别:
Ampicillin resistance mechanisms in E. faecium
屎肠球菌的氨苄西林耐药机制
  • 批准号:
    7070636
  • 财政年份:
    2001
  • 资助金额:
    $ 37.61万
  • 项目类别:

相似海外基金

Cellular membrane affinity chromatography kit for drug discovery
用于药物发现的细胞膜亲和层析试剂盒
  • 批准号:
    10506915
  • 财政年份:
    2021
  • 资助金额:
    $ 37.61万
  • 项目类别:
Cellular membrane affinity chromatography kit for drug discovery
用于药物发现的细胞膜亲和层析试剂盒
  • 批准号:
    10325006
  • 财政年份:
    2021
  • 资助金额:
    $ 37.61万
  • 项目类别:
SBIR Phase I: A New Class of Immobilized Metal Affinity Chromatography Resins
SBIR 第一阶段:一类新型固定金属亲和色谱树脂
  • 批准号:
    1746198
  • 财政年份:
    2018
  • 资助金额:
    $ 37.61万
  • 项目类别:
    Standard Grant
Marine speciation of nickel using immobilized nickel affinity chromatography
使用固定镍亲和色谱法测定镍的海洋形态
  • 批准号:
    512537-2017
  • 财政年份:
    2017
  • 资助金额:
    $ 37.61万
  • 项目类别:
    University Undergraduate Student Research Awards
I-Corps: Commercialization of Immobilized Metal Affinity Chromatography Resins Based on Nanomaterials
I-Corps:基于纳米材料的固定化金属亲和层析树脂的商业化
  • 批准号:
    1404605
  • 财政年份:
    2014
  • 资助金额:
    $ 37.61万
  • 项目类别:
    Standard Grant
Antibody Purification via Affinity Chromatography that Utilizes the Unconventional Nucleotide Binding Site
利用非常规核苷酸结合位点通过亲和色谱法纯化抗体
  • 批准号:
    1263713
  • 财政年份:
    2013
  • 资助金额:
    $ 37.61万
  • 项目类别:
    Continuing Grant
Development of multivalent DNA network based affinity chromatography diagnostics for isolating circulating tumour cells
开发基于多价 DNA 网络的亲和色谱诊断法,用于分离循环肿瘤细胞
  • 批准号:
    425749-2012
  • 财政年份:
    2012
  • 资助金额:
    $ 37.61万
  • 项目类别:
    Postgraduate Scholarships - Master's
Next-Generation Affinity Chromatography with PEGylated Ligands
使用聚乙二醇化配体的新一代亲和色谱法
  • 批准号:
    1159886
  • 财政年份:
    2012
  • 资助金额:
    $ 37.61万
  • 项目类别:
    Standard Grant
Immobilized zirconium ion affinity chromatography for specific enrichment of phosphoproteins
用于磷蛋白特异性富集的固定化锆离子亲和层析
  • 批准号:
    19560760
  • 财政年份:
    2007
  • 资助金额:
    $ 37.61万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Accelerating drug discovery using frontal affinity chromatography/mass spectrometry
使用正面亲和色谱/质谱加速药物发现
  • 批准号:
    234753-2000
  • 财政年份:
    2003
  • 资助金额:
    $ 37.61万
  • 项目类别:
    Collaborative Research and Development Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了